{"transactions":[{"id":778914,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T22:32:29.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-224521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224521/ownership.xml","form_type":"4"}},{"id":778913,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:27:40.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-224148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224148/ownership.xml","form_type":"4"}},{"id":778912,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:26:26.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10683,"source":{"system":"sec-edgar","filing":"0001193125-26-224140","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224140/ownership.xml","form_type":"4"}},{"id":778911,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47319,"kind":"person","name":"Finn Jonathan","position":1,"cik":"0001981595","reported_name":"Finn Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:25:53.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":11666,"source":{"system":"sec-edgar","filing":"0001193125-26-224135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224135/ownership.xml","form_type":"4"}},{"id":778910,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:25:23.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10006,"source":{"system":"sec-edgar","filing":"0001193125-26-224133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224133/ownership.xml","form_type":"4"}},{"id":779480,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47394,"kind":"person","name":"Cigler Tessa","position":1,"cik":"0002015142","reported_name":"Cigler Tessa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:24:42.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-224125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015142/000119312526224125/ownership.xml","form_type":"4"}},{"id":824646,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-31T16:57:01.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal annual installments on the first three anniversaries of March 26, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 2, 2026, the Issuer effected a one-for-fifteen reverse stock split of its Common Stock (the \"Reverse Stock Split\"). The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":88038,"source":{"system":"sec-edgar","filing":"0001193125-26-134861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000119312526134861/ownership.xml","form_type":"4"}},{"id":825476,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55389,"kind":"person","name":"Daniel Mark James","position":1,"cik":"0002092593","reported_name":"Daniel Mark James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-30T19:22:50.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal annual installments on the first three anniversaries of March 26, 2026."}],"balance_after":63000,"source":{"system":"sec-edgar","filing":"0001193125-26-132644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092593/000119312526132644/ownership.xml","form_type":"4"}},{"id":927405,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Options (right to buy)","published_at":"2026-01-30T08:30:03.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":950000,"price":0.603,"value":572850.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options shall vest on a quarterly basis over 24 months following January 20, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on January 20, 2026, with an exercise price of $0.603, representing the closing stock price on January 20, 2026."}],"balance_after":950000,"derivative":{"exercise_price":0.603,"expiration_date":"2026-01-20","underlying":"Common Stock","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001193125-26-030571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000119312526030571/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-22"}},{"id":927404,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-30T08:30:03.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":331674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the acquisition of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest one year from the Transaction Date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The original Form 4, filed on January 22, 2026, is being amended by this Form 4 amendment solely to correct an administrative error regarding the number of RSUs acquired."}],"balance_after":345572,"source":{"system":"sec-edgar","filing":"0001193125-26-030571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000119312526030571/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-22"}},{"id":933670,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Options (right to buy)","published_at":"2026-01-22T14:11:52.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":950000,"price":0.603,"value":572850.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options shall vest on a quarterly basis over 24 months following January 20, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on January 20, 2026, with an exercise price of $0.603, representing the closing stock price on January 20, 2026."}],"balance_after":950000,"derivative":{"exercise_price":0.603,"expiration_date":"2026-01-20","underlying":"Common Stock","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001193125-26-019273","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000119312526019273/ownership.xml","form_type":"4"}},{"id":933669,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-22T14:11:52.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":325203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest one year from the Transaction date."}],"balance_after":339101,"source":{"system":"sec-edgar","filing":"0001193125-26-019273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000119312526019273/ownership.xml","form_type":"4"}},{"id":1015388,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55389,"kind":"person","name":"Daniel Mark James","position":1,"cik":"0002092593","reported_name":"Daniel Mark James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-21T16:10:03.000Z","date":"2025-10-14","kind":"grant","planned":false,"acquired":true,"shares":578000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest with respect to 25% on October 14, 2026, with the remaining 75% to vest in equal quarterly installments over the follwing three years, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":578000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-10-14","underlying":"Common Stock","underlying_shares":578000},"source":{"system":"sec-edgar","filing":"0001193125-25-245114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092593/000119312525245114/ownership.xml","form_type":"4"}},{"id":1138042,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-22T18:27:25.000Z","date":"2025-05-21","kind":"purchase","planned":false,"acquired":true,"shares":11239,"price":0.8797,"value":9886.9483,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.8794 to $0.9100. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of share purchased at each separate price."}],"balance_after":13898,"source":{"system":"sec-edgar","filing":"0000950170-25-076523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000095017025076523/ownership.xml","form_type":"4"}},{"id":1145300,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47319,"kind":"person","name":"Finn Jonathan","position":1,"cik":"0001981595","reported_name":"Finn Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:23.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073522/ownership.xml","form_type":"4"}},{"id":1145297,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:22.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073521/ownership.xml","form_type":"4"}},{"id":1145298,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:12.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073517/ownership.xml","form_type":"4"}},{"id":1145296,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:10.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073516/ownership.xml","form_type":"4"}},{"id":1145753,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47394,"kind":"person","name":"Cigler Tessa","position":1,"cik":"0002015142","reported_name":"Cigler Tessa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:09.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015142/000095017025073515/ownership.xml","form_type":"4"}},{"id":1145295,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:09.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073513","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073513/ownership.xml","form_type":"4"}},{"id":1146104,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T16:05:17.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":1366062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 24 months following May 15, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on May 15, 2025, with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":1366062,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":1366062},"source":{"system":"sec-edgar","filing":"0000950170-25-073520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000095017025073520/ownership.xml","form_type":"4"}},{"id":1145728,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":79685,"kind":"person","name":"Rees Heather","position":1,"cik":"0001997454","reported_name":"Rees Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T16:05:13.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":543785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 24 months following May 15, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on May 15, 2025, with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":543785,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":543785},"source":{"system":"sec-edgar","filing":"0000950170-25-073518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997454/000095017025073518/ownership.xml","form_type":"4"}},{"id":1188798,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-28T20:00:03.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.7,"value":7000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects a reverse stock split of the Issuer's common stock at a ratio of 12:1 effective April 2018. The Reporting Person disclaims beneficial ownership of 11 shares of common stock owned by his spouse except to the extent of his pecuniary interest in the shares."}],"balance_after":10257,"source":{"system":"sec-edgar","filing":"0000950170-25-046742","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025046742/ownership.xml","form_type":"4"}},{"id":1465742,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47319,"kind":"person","name":"Finn Jonathan","position":1,"cik":"0001981595","reported_name":"Finn Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:15.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079565/ownership.xml","form_type":"4"}},{"id":1465741,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:12.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079562/ownership.xml","form_type":"4"}},{"id":1465740,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:11.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079563/ownership.xml","form_type":"4"}},{"id":1465738,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:10.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079561/ownership.xml","form_type":"4"}},{"id":1465739,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:06.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079558/ownership.xml","form_type":"4"}},{"id":1466093,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47394,"kind":"person","name":"Cigler Tessa","position":1,"cik":"0002015142","reported_name":"Cigler Tessa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:05.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079557","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015142/000095017024079557/ownership.xml","form_type":"4"}},{"id":1466078,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":79685,"kind":"person","name":"Rees Heather","position":1,"cik":"0001997454","reported_name":"Rees Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and Accounting"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T16:00:09.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":577700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 24 months following June 27, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024, with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":577700,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":577700},"source":{"system":"sec-edgar","filing":"0000950170-24-079560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997454/000095017024079560/ownership.xml","form_type":"4"}},{"id":1466479,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T16:00:07.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":1795100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 24 months following June 27, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024, with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":1795100,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":1795100},"source":{"system":"sec-edgar","filing":"0000950170-24-079559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000095017024079559/ownership.xml","form_type":"4"}},{"id":1543113,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47319,"kind":"person","name":"Finn Jonathan","position":1,"cik":"0001981595","reported_name":"Finn Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-11T20:05:09.000Z","date":"2024-04-10","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.77,"value":44250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $1.74 to $1.78. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, The Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000950170-24-043690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024043690/ownership.xml","form_type":"4"}},{"id":1577023,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47394,"kind":"person","name":"Cigler Tessa","position":1,"cik":"0002015142","reported_name":"Cigler Tessa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-15T00:35:06.000Z","date":"2024-03-09","kind":"grant","planned":false,"acquired":true,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in four equal quarterly installments following March 9, 2024, subject to the Reporting Person's continued service through each applicable date."}],"balance_after":20834,"derivative":{"exercise_price":1.09,"expiration_date":"2034-03-09","underlying":"Common Stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0000950170-24-031815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015142/000095017024031815/ownership.xml","form_type":"4"}},{"id":1736632,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true,"officer":true,"officer_title":"Former EVP, CFO, & Director"}}],"security":"Common Stock","published_at":"2023-11-17T21:01:39.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":0.65,"value":32500.0,"ownership":{"direct":true},"balance_after":55,"source":{"system":"sec-edgar","filing":"0001437749-23-032461","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923032461/rdgdoc.xml","form_type":"4"}},{"id":1740633,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47319,"kind":"person","name":"Finn Jonathan","position":1,"cik":"0001981595","reported_name":"Finn Jonathan","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-11-15T22:03:55.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in four equal quarterly installments following November 15, 2023."}],"balance_after":62500,"derivative":{"exercise_price":0.65,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-23-032191","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923032191/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-11-15"}},{"id":1740632,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47319,"kind":"person","name":"Finn Jonathan","position":1,"cik":"0001981595","reported_name":"Finn Jonathan","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-11-15T21:05:28.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in four equal quarterly installments following November 15, 2023."}],"balance_after":62500,"derivative":{"exercise_price":0,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-23-032166","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923032166/rdgdoc.xml","form_type":"4"}},{"id":1849494,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true,"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2023-06-21T00:15:24.000Z","date":"2023-06-20","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.97,"value":48500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock purchased on November 21, 2013, which were previously reported on a Form 4 filed by the Reporting Person on November 22, 2013 but erroneously omitted in subsequent filings."}],"balance_after":50055,"source":{"system":"sec-edgar","filing":"0001437749-23-017896","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923017896/rdgdoc.xml","form_type":"4"}},{"id":1866986,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true,"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T13:00:29.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":2600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest with respect to 25% on the one year anniversary of June 1, 2023, and the remainder shall vest in equal quarterly installments over the following three years, subject to the reporting person's continued service through each applicable vesting date."}],"balance_after":2600000,"derivative":{"exercise_price":0.92,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":2600000},"source":{"system":"sec-edgar","filing":"0001437749-23-016569","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923016569/rdgdoc.xml","form_type":"4"}},{"id":1902692,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:36:21.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012872","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012872/rdgdoc.xml","form_type":"4"}},{"id":1902693,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:36:00.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012871","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012871/rdgdoc.xml","form_type":"4"}},{"id":1902691,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:35:42.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012870","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012870/rdgdoc.xml","form_type":"4"}},{"id":1902690,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:35:21.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012869","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012869/rdgdoc.xml","form_type":"4"}},{"id":1902689,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:35:00.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012868","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012868/rdgdoc.xml","form_type":"4"}},{"id":1969004,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T21:10:36.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":557900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date."}],"balance_after":557900,"derivative":{"exercise_price":0.72,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":557900},"source":{"system":"sec-edgar","filing":"0001437749-23-005531","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923005531/rdgdoc.xml","form_type":"4"}},{"id":1970007,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option  (right to buy)","published_at":"2023-03-06T16:11:04.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":1873100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date."}],"balance_after":1873100,"derivative":{"exercise_price":0.72,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":1873100},"source":{"system":"sec-edgar","filing":"0001437749-23-005533","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000143774923005533/rdgdoc.xml","form_type":"4"}},{"id":2270263,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:24:38.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":50000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012713","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012713/rdgdoc.xml","form_type":"4"}},{"id":2270261,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:23:21.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":50000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012712","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012712/rdgdoc.xml","form_type":"4"}},{"id":2270262,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:21:20.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":50000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012711","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012711/rdgdoc.xml","form_type":"4"}},{"id":2270260,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:20:16.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":500000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012710","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012710/rdgdoc.xml","form_type":"4"}},{"id":2270259,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:19:09.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":50000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012709","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012709/rdgdoc.xml","form_type":"4"}},{"id":2368967,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-28T22:15:57.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":746667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on a quarterly basis over two (2) years."}],"balance_after":746667,"derivative":{"exercise_price":1.25,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":746667},"source":{"system":"sec-edgar","filing":"0001437749-22-004668","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922004668/rdgdoc.xml","form_type":"4"}},{"id":2369932,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-28T17:15:56.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on a quarterly basis over two (2) years."}],"balance_after":1900000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001437749-22-004667","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000143774922004667/rdgdoc.xml","form_type":"4"}},{"id":2639321,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options were granted on May 15, 2020, vested on a quarterly basis over 12 months and expire 10 years from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These options were granted on May 15, 2020, vested on a quarterly basis over 12 months and expire 10 years from the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.7,"underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639320,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options were granted on May 17, 2019, vested on a quarterly basis over 12 months and expire 10 years from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These options were granted on May 17, 2019, vested on a quarterly basis over 12 months and expire 10 years from the grant date."}],"balance_after":0,"derivative":{"exercise_price":2.52,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639319,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on June 27, 2018, vested on a quarterly basis over 12 months and expire 10 years from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These options were granted on June 27, 2018, vested on a quarterly basis over 12 months and expire 10 years from the grant date."}],"balance_after":0,"derivative":{"exercise_price":2.38,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639318,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":4581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on May 24, 2017, vested on a quarterly basis over 12 months and expire 10 years from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These options were granted on May 24, 2017, vested on a quarterly basis over 12 months and expire 10 years from the grant date."}],"balance_after":0,"derivative":{"exercise_price":5.64,"underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639317,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":107497,"price":5.58,"value":599833.26,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $5.51 to $5.65. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639316,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":57084,"price":6.4,"value":365337.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the Nasdaq closing price of the Issuer's common stock on July 01, 2021."}],"balance_after":107497,"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639315,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":70000,"price":1.7,"value":119000.0,"ownership":{"direct":true},"balance_after":164581,"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639314,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":45000,"price":2.52,"value":113400.0,"ownership":{"direct":true},"balance_after":94581,"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639313,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":45000,"price":2.38,"value":107100.0,"ownership":{"direct":true},"balance_after":49581,"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2639312,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-07T20:29:44.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":4581,"price":5.64,"value":25836.84,"ownership":{"direct":true},"balance_after":4581,"source":{"system":"sec-edgar","filing":"0001437749-21-016573","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921016573/rdgdoc.xml","form_type":"4"}},{"id":2708037,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:54.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012678","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012678/rdgdoc.xml","form_type":"4"}},{"id":2708036,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:45.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":850000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001437749-21-012675","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012675/rdgdoc.xml","form_type":"4"}},{"id":2708035,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:40.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012677","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012677/rdgdoc.xml","form_type":"4"}},{"id":2708034,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:08.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012673/rdgdoc.xml","form_type":"4"}},{"id":2708033,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:16:41.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012671","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012671/rdgdoc.xml","form_type":"4"}},{"id":2708032,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:16:30.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2020 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012672","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012672/rdgdoc.xml","form_type":"4"}},{"id":2708857,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T16:18:50.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":1900000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001437749-21-012676","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000143774921012676/rdgdoc.xml","form_type":"4"}},{"id":2708858,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T16:18:22.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":1900000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001437749-21-012674","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000143774921012674/rdgdoc.xml","form_type":"4"}},{"id":3142662,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:06:57.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-20-011265","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011265/rdgdoc.xml","form_type":"4"}},{"id":3142661,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:06:33.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":70000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001437749-20-011264","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011264/rdgdoc.xml","form_type":"4"}},{"id":3142660,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:06:12.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-20-011263","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011263/rdgdoc.xml","form_type":"4"}},{"id":3142659,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:05:51.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-20-011262","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011262/rdgdoc.xml","form_type":"4"}},{"id":3142658,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:05:31.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-20-011261","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011261/rdgdoc.xml","form_type":"4"}},{"id":3177925,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T22:21:03.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":395000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates.  However, 50% of all then-unvested options will vest immediately upon the achievement of certain milestones. The stock options are also subject to stockholder approval of the 2020 Stock Incentive Plan of the Company, which approval must occur within one year from the grant date."}],"balance_after":395000,"derivative":{"exercise_price":1.48,"expiration_date":"2030-04-09","underlying":"Common Shares","underlying_shares":395000},"source":{"system":"sec-edgar","filing":"0001437749-20-007630","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920007630/rdgdoc.xml","form_type":"4"}},{"id":3177924,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T22:21:03.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates."}],"balance_after":195000,"derivative":{"exercise_price":1.48,"expiration_date":"2030-04-09","underlying":"Common Shares","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001437749-20-007630","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920007630/rdgdoc.xml","form_type":"4"}},{"id":3178189,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T18:20:39.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":1305000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates.  However, 50% of all then-unvested options will vest immediately upon the achievement of certain milestones. The stock options are also subject to stockholder approval of the 2020 Stock Incentive Plan of the Company, which approval must occur within one year from the grant date."}],"balance_after":1305000,"derivative":{"exercise_price":1.48,"expiration_date":"2030-04-09","underlying":"Common Shares","underlying_shares":1305000},"source":{"system":"sec-edgar","filing":"0001437749-20-007628","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000143774920007628/rdgdoc.xml","form_type":"4"}},{"id":3178188,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T18:20:39.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates."}],"balance_after":195000,"derivative":{"exercise_price":1.48,"expiration_date":"2030-04-09","underlying":"Common Shares","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001437749-20-007628","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000143774920007628/rdgdoc.xml","form_type":"4"}},{"id":3516849,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:23.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010648","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010648/rdgdoc.xml","form_type":"4"}},{"id":3516848,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:17.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010647","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010647/rdgdoc.xml","form_type":"4"}},{"id":3516847,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:13.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2019-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010646","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010646/rdgdoc.xml","form_type":"4"}},{"id":3516846,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:06.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010645","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010645/rdgdoc.xml","form_type":"4"}},{"id":3516845,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:00.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010644","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010644/rdgdoc.xml","form_type":"4"}},{"id":3695496,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T21:10:29.000Z","date":"2019-01-13","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to stockholder approval of the option grant, the option will vest and be exercisable with respect to: (i) 25% of the underlying shares as of the grant date (January 13, 2019), (ii) 50% of the underlying shares over a two-year period (vesting ratably quarterly) from June 27, 2018, and (iii) 25% of the underlying shares upon achievement of certain milestones. If the option grant is not approved by stockholders, then the option will not be exercisable."}],"balance_after":800000,"derivative":{"exercise_price":1.36,"expiration_date":"2029-01-13","underlying":"Common Shares","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001615774-19-000644","document":"s115378_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577419000644/s115378_form4.xml","form_type":"4"}},{"id":3695495,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T21:10:29.000Z","date":"2019-01-13","kind":"disposition_to_issuer","acquired":false,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the options were vested as of the grant date (June 27, 2018), 50% of the options will vest quarterly over two years from the grant date, and the remaining 25% will vest upon achievement of certain milestones."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Shares","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001615774-19-000644","document":"s115378_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577419000644/s115378_form4.xml","form_type":"4"}},{"id":3695791,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T16:10:46.000Z","date":"2019-01-13","kind":"grant","acquired":true,"shares":2300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to stockholder approval of the option grant, the option will vest and be exercisable with respect to: (i) 25% of the underlying shares as of the grant date (January 13, 2019), (ii) 50% of the underlying shares over a two-year period (vesting ratably quarterly) from June 27, 2018, and (iii) 25% of the underlying shares upon achievement of certain milestones. If the option grant is not approved by stockholders, then the option will not be exercisable."}],"balance_after":2300000,"derivative":{"exercise_price":1.36,"expiration_date":"2029-01-13","underlying":"Common Shares","underlying_shares":2300000},"source":{"system":"sec-edgar","filing":"0001615774-19-000645","document":"s115379_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000161577419000645/s115379_form4.xml","form_type":"4"}},{"id":3695790,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T16:10:46.000Z","date":"2019-01-13","kind":"disposition_to_issuer","acquired":false,"shares":2300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the options were vested as of the grant date (June 27, 2018), 50% of the options will vest quarterly over two years from the grant date, and the remaining 25% will vest upon achievement of certain milestones."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Shares","underlying_shares":2300000},"source":{"system":"sec-edgar","filing":"0001615774-19-000645","document":"s115379_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000161577419000645/s115379_form4.xml","form_type":"4"}},{"id":3880465,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:04:29.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones."}],"balance_after":700000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001615774-18-006001","document":"s111134_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418006001/s111134_form4.xml","form_type":"4"}},{"id":3880464,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:04:05.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-006000","document":"s111133_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418006000/s111133_form4.xml","form_type":"4"}},{"id":3880463,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":10174,"kind":"person","name":"Steinhart Richard I","position":1,"cik":"0001293789","reported_name":"Steinhart Richard I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:03:41.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-005998","document":"s111132_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418005998/s111132_form4.xml","form_type":"4"}},{"id":3880462,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:02:51.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-005996","document":"s111130_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418005996/s111130_form4.xml","form_type":"4"}},{"id":3880461,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47318,"kind":"person","name":"Galli Stephen J","position":1,"cik":"0001551951","reported_name":"Galli Stephen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:02:31.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-005995","document":"s111129_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418005995/s111129_form4.xml","form_type":"4"}},{"id":3880459,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":27161,"kind":"person","name":"WEAVER GREGORY L","position":1,"cik":"0001251779","reported_name":"WEAVER GREGORY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:02:11.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-005994","document":"s111128_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418005994/s111128_form4.xml","form_type":"4"}},{"id":3880781,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T16:03:14.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":2300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones."}],"balance_after":2300000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":2300000},"source":{"system":"sec-edgar","filing":"0001615774-18-005997","document":"s111131_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000161577418005997/s111131_form4.xml","form_type":"4"}},{"id":3912510,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-05-31T19:29:07.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":2272,"price":1000,"value":2272000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are owned by Ensisheim Partners, LLC (\"Ensisheim\"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity."}],"balance_after":2272,"derivative":{"exercise_price":4.05,"exercise_date":"2018-05-30","expiration_date":"2022-05-30","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001615774-18-004659","document":"s110547_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004659/s110547_form4.xml","form_type":"4"}},{"id":3912509,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-05-31T19:29:07.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":8,"price":1000,"value":8000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series B Convertible Preferred Stock do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are owned by Ensisheim Partners, LLC (\"Ensisheim\"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity."}],"balance_after":8,"derivative":{"exercise_price":3.52,"exercise_date":"2018-05-30","underlying":"Common Stock","underlying_shares":2273},"source":{"system":"sec-edgar","filing":"0001615774-18-004659","document":"s110547_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004659/s110547_form4.xml","form_type":"4"}},{"id":3912508,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Warrants","published_at":"2018-05-31T19:24:48.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":2272,"price":1000,"value":2272000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."}],"balance_after":2272,"derivative":{"exercise_price":4.05,"exercise_date":"2018-05-30","expiration_date":"2022-05-30","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001615774-18-004655","document":"s110545_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004655/s110545_form4.xml","form_type":"4"}},{"id":3912507,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-05-31T19:24:48.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":8,"price":1000,"value":8000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series B Convertible Preferred Stock do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share."}],"balance_after":8,"derivative":{"exercise_price":3.52,"exercise_date":"2018-05-30","underlying":"Common Stock","underlying_shares":2273},"source":{"system":"sec-edgar","filing":"0001615774-18-004655","document":"s110545_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004655/s110545_form4.xml","form_type":"4"}},{"id":3913075,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55175,"kind":"person","name":"QUAY STEVEN C","position":1,"cik":"0001008227","reported_name":"QUAY STEVEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Warrants","published_at":"2018-05-31T15:26:44.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":2272,"price":1000,"value":2272000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are owned by Ensisheim Partners, LLC (\"Ensisheim\"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity."}],"balance_after":2272,"derivative":{"exercise_price":4.05,"exercise_date":"2018-05-30","expiration_date":"2022-05-30","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001615774-18-004657","document":"s110546_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008227/000161577418004657/s110546_form4.xml","form_type":"4"}}],"next_cursor":"2018-05-31T15:26:44.000000Z,3913075"}